allfeeds.ai

 

Medscape InDiscussion: Lung Cancer  

Medscape InDiscussion: Lung Cancer

Author: Medscape

Listen to Medscape InDiscussion: Lung Cancer, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984257). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Be a guest on this podcast

Language: en

Genres: Health & Fitness, Medicine, Science

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it


Get all podcast data

Listen Now...

S3 Episode 6: NUT Carcinoma: Diagnostic Challenges, Emerging Treatments, and Clinical Trials
Episode 6
Tuesday, 9 July, 2024

Drs Jacob Sands and Jia Luo discuss NUT carcinoma, including diagnostic challenges, emerging treatments, clinical trial options, and the NUT carcinoma registry. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999032. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics https://pubmed.ncbi.nlm.nih.gov/35372003/ The MYC Oncogene — The Grand Orchestrator of Cancer Growth and Immune Evasion https://pubmed.ncbi.nlm.nih.gov/34508258/ SOX2 Is an Oncogenic Driver of Small-Cell Lung Cancer and Promotes the Classic Neuroendocrine Subtype https://pubmed.ncbi.nlm.nih.gov/34593608/ Next-Generation Sequencing in Cancer https://pubmed.ncbi.nlm.nih.gov/34408360/ PET Scanning https://www.ncbi.nlm.nih.gov/books/NBK559089/ Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma https://pubmed.ncbi.nlm.nih.gov/38154515/ International NUT Carcinoma Registry https://nc-registry.org/ Automated Tumor Proportion Score Analysis for PD-L1 (22C3) Expression in Lung Squamous Cell Carcinoma https://pubmed.ncbi.nlm.nih.gov/34354151/ Ewing Sarcoma https://emedicine.medscape.com/article/990378-overview?form=fpf Improving Lung Cancer Patient Care Through Collaboration, Psychology, and Communication https://www.medscape.com/viewarticle/999028 BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications https://pubmed.ncbi.nlm.nih.gov/37049806/ Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Etoposide and Cisplatin) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma https://clinicaltrials.gov/study/NCT05019716 Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors https://clinicaltrials.gov/study/NCT05372640 Development of CDK4/6 Inhibitors: A Five Years Update https://pubmed.ncbi.nlm.nih.gov/33803309/ A Dose Escalation and Cohort Expansion Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma https://www.clinicaltrials.gov/search?cond=NCT04718675 Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05488548

 

We also recommend:


Rapport: The Informal Ethnographer Podcast

Physics Experiments - SD

Moons of the Solar System - for iPod/iPhone
The Open University

ABB Power Talk
ABB High Voltage Academy

A Woman in Arboriculture
Jacqui Waring

Tropical Rain Forests are Disappearing
Kailey Williams

Its the most wonderful time, to time travel.
Justin Yang

From the Earth to the Moon: A Retrospective Podcast on The Apollo Program
Doug & Peter

Accendi il tuo Potenziale
Irene Aldanese

Winter Blues
Alex Vinklarek

Tæt på retsmedicin
Institut for Retsmedicin, Aarhus Universitet

RadioLacan.com | Odios? Introducción a la conversación Encarnaciones del odio. Racismos, sexismos, crueldades coti